Oral Ribavirin for the Treatment of Respiratory Syncytial Virus Infection in Allogeneic Stem Cell Transplant Recipients-Utility of the Immunodeficiency Scoring Index for Risk Stratification

Journal article

Open access

Moussab Damlaj, Gabriel Bartoo, Desire Gijima, Shahrukh Hashmi, Mark R. Litzow, William Hogan and Mrinal Patnaik

Biology of blood and marrow transplantation, Vol.21(2), pp.S173-S174

01/02/2015

Files and links (1)

url

https://doi.org/10.1016/j.bbmt.2014.11.255View

Published (Version of record) Open

1 Record Views

Title: Oral Ribavirin for the Treatment of Respiratory Syncytial Virus Infection in Allogeneic Stem Cell Transplant Recipients-Utility of the Immunodeficiency Scoring Index for Risk Stratification
Creators - without role: Moussab Damlaj - Mayo Clinic in Florida
Gabriel Bartoo - Mayo Clinic in Florida
Desire Gijima - University of Iowa
Shahrukh Hashmi - Mayo Clinic in Florida
Mark R. Litzow - Mayo Clinic in Arizona
William Hogan - Mayo Clinic
Mrinal Patnaik - Mayo Clinic in Arizona
Publication Details: Biology of blood and marrow transplantation, Vol.21(2), pp.S173-S174
Publisher: Elsevier Inc
Identifiers: 9921242308331
Academic Unit: King Abdulaziz University; King Saud Bin Abdulaziz University for Health Sciences
Language: English
Resource Type: Journal article